Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-24 | New | $13,807,138 | $13,807,138 | Equity Only | 06b | SEC link |
| 2022-10-11 | Amended | $9,943,000 | $5,626,000 | Debt Only | 06b | SEC link |
| 2021-08-27 | New | $4,317,000 | $4,317,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Mark De Souza | Director, Executive |
| Hal Landy | Director |
| Joff Masukawa | Director |
| John Parker | Director |
| Deborah Ramsdell | Director, Executive |
| Philip Reilly | Director |
| Alexander Silver | Director |